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Abstract
Anxiety disorders affect roughly 40 million 
American adults in a given year. Those suffering 
from anxiety disorders often experience additional 
stress-linked illnesses, such as depression. Previous 
research has shown that stress exposure increases 
levels of  the endogenous neuropeptide dynorphin, 
which the kappa opioid system is selectively ac-
tivated by. This study examined the role of  the 
kappa opioid system in regulating stress-related 
behavior using the elevated plus-maze. Behavioral 
stress responses were examined in male Wistar 
rats following i.p. administration of  opioid ago-
nist U-50,488 (0 or 10 mg/kg). Subjects were 
pretreated with the kappa opioid antagonist nor-
binaltorphimine (nor-BNI) 24 hours prior to test-
ing in the elevated plus-maze (0 or 20 mg/kg). 
Injections of  10 mg/kg U-50,488 significantly 
decreased percent open arm time compared to con-
trols, an effect reversed by pretreatment with 20 
mg/kg nor-BNI (F(1,44) = 6.10, p < 0.05). 
A main effect of  nor-BNI was found on the total 
number of  arm entries (F(1,44) = 11.73, p < 
0.05). Further analysis revealed that pretreat-
ment with nor-BNI led to an increased number 
of  arm entries in rats injected with U-50,488. 
The nor-BNI sensitivity of  the behavioral re-
sponses suggests an activation of  the kappa opioid 
receptors by a stress-induced release of  dynorphin. 
The results indicate a relationship between kappa 
opioid receptors and stress-related behaviors and 
illustrate the potential therapeutic value of  target-
ing the kappa opioid system in the treatment of  
anxiety and other stress-related disorders.
Introduction
Anxiety disorders affect roughly 40 mil-
lion American adults (about 18% of  the 
US population) in a given year (Kessler, 
2005).  In addition, those suffering from 
an anxiety disorder often experience co-
morbidity with other stress-linked mental 
illnesses such as depression and alcohol 
and drug abuse, suggesting that stress is a 
critical component in the development of  
these disorders.
A classic definition of  stress is any re-
sponse to demands, usually noxious, placed 
on the body (Selye, 1936).  An alternate 
definition describes stress as any alterations 
in the psychological homeostatic process 
(Burchfield, 1979).  Although exposure to 
certain levels of  stress is a normal occur-
rence in everyday life, chronic stress can 
lead to the development of  psychiatric 
disorders, such as anxiety and depression 
(Hennessy & Levine, 1979).  Stress has 
been found to increase the release of  sev-
eral endogenous neurochemicals, includ-
ing dynorphin (Nabeshima, et al., 1992), a 
neuropeptide that binds with high affinity 
to kappa opioid receptors (Chavkin, et al., 
1982).
Recent evidence suggests the involve-
ment of  the dynorphin/kappa opioid 
receptor (KOR) system in mediating the 
stress responses.  McLaughlin, et al. (2003) 
investigated the involvement of  the kappa 
opioid system in the stress response by ex-
amining the behavior of  mice subjected 
to forced swim stress.  Mice lacking the 
prodynorphin gene showed a significant 
reduction in stress-induced immobility, an 
indication of  depression-like behavior, in 
the forced swim test.  Similar results were 
found in mice pretreated with the kappa 
opioid antagonist nor-binaltorphimine 
(nor-BNI).  In addition, tests using social 
defeat stress (SDS) found prodynorphin 
knockout mice and those that received nor-
BNI pretreatment to spend significantly 
less time in socially defeated, immobile 
postures (McLaughlin, et al., 2006).  Taken 
together, these results implicate a role of  
the dynorphin/KOR system in behavioral 
responses to stress.
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The dynorphin/KOR system has also 
been examined in stress-related reinstate-
ment of  drug seeking (Beardsley, et al., 
2005; Valdez, et al., 2007).  The KOR an-
tagonist JDTic was found to block stress-
induced reinstatement of  cocaine seeking. 
It also decreased time spent immobile 
in the forced swim test, suggesting the 
antistress potential of  KOR antagonists 
(Beardsley, et al., 2005).  Another study 
found that the KOR agonists spiradoline 
and enadoline led to reinstatement of  
cocaine-seeking behavior in squirrel mon-
keys, but this effect was not reversed by the 
antagonist nor-BNI (Valdez, et al., 2007). 
These results suggest a possible mediation 
of  stress-related behavior by a subpopula-
tion of  kappa opioid receptors.  However, 
blockade of  corticotropin releasing factor 
and norephinephrine, two brain systems 
also thought to be mediators of  the stress 
response (Koob, 1999), prevented spira-
doline-induced reinstatement.  Although 
these findings suggest that brain kappa 
opioid system is involved in the regulation 
of  stress-related behaviors, additional re-
search is needed to understand the role of  
the KOR system.
The purpose of  this study was to exam-
ine the role of  the kappa opioid system in 
regulating behavioral responses to stress. 
The effects of  U-50,488 on stress-related 
behavior were examined in the elevated 
plus-maze, a classic animal model of  anx-
iety (Pellow & File, 1986).  In addition, 
the effects of  the selective antagonist nor-
BNI administered as a pretreatment to 
U-50,488 were examined.  The results of  
this experiment reveal the ability of  nor-
BNI to reduce stress-induced increases 
in anxiety-like behavior, suggesting that 
kappa opioid mechanisms are involved 
in the regulation of  behaviors induced by 
external stressors. 
Materials and Methods
Animals and Housing
 Male Wistar rats (Charles River, Kings-
ton, NY; n=45) weighing 150-200 g upon 
arrival were used in this experiment.  Rats 
were habituated to colony housing 14 
days prior to testing.  Rats were housed 
in groups of  2-3 per cage with food and 
water available ad libitum.  Rats were han-
dled and weighed daily to minimize any 
stress associated with the experimental 
procedure.  Animals were maintained on 
a 12-hr reverse light/dark cycle (lights on 
at 10:00 PM). 
Apparatus
 The elevated plus-maze (Med Associ-
ates, St. Albans, VT) measures uncondi-
tioned approach-avoidance behavior dur-
ing exploration of  a novel environment in 
rats (Pellow & File, 1986).  The apparatus 
was made of  dark Plexiglas and consisted 
of  four arms (50 cm long X 10 cm wide). 
The two enclosed arms had 40 cm high 
dark walls, whereas the two open arms 
had 0.5 cm high ledges.  The maze was 
elevated to a height of  50 cm. 
Drugs
U50-488 [(trans)-3,4-dichloro-N-meth-
yl-N-[2-(1-pyrrolidinyl)-cyclo-hexyl] ben-
zeneacetamide; Tocris Biosciences, El-
lisville, MO] and nor-binaltorphimine 
(nor-BNI; Tocris Biosciences, Ellisville, 
MO) were dissolved in 0.9% saline solu-
tion for i.p. injections.
Behavioral testing procedure
 Rats received intraperitoneal (i.p.) in-
jections of  nor-BNI (0 or 20 mg/kg) at 
least 24 hours prior to testing in the ele-
vated plus-maze.  This pretreatment peri-
od was chosen because previous research 
has shown that nor-BNI is most selective 
for kappa opioid receptors at 24 hours as 
opposed to earlier time points (Endoh, et 
al., 1992).  On the day of  testing, rats were 
further divided into groups receiving dif-
ferent doses of  U-50,488 (0 or 10 mg/kg). 
Injections of  U-50,488 took place 10 min-
utes prior to testing in the elevated plus-
maze. 
 To examine anxiety-like behavior and 
general motor activity, rats were placed 
individually onto the center of  the appa-
ratus facing a closed arm.  The time spent 
on and entries onto each arm were re-
corded automatically by photocell beams 
and monitored by a computer for 5 min-
utes.  The percentage of  time spent ex-
ploring the open arms has been proposed 
to relate inversely to an anxiety-like state, 
whereas the number of  arm entries mea-
sures general locomotor activity (Pellow, et 
al., 1985). 
Data Analysis
 Data were analyzed using two-way 
analysis of  variance (ANOVA) with dose 
of  U-50,488 and dose of  nor-BNI as be-
tween subjects factors.  Further analysis 
was performed using the Tukey’s post hoc 
test as warranted. 
Results
There was a significant interaction be-
tween U-50,488 dose and nor-BNI dose 
on the percentage of  time spent explor-
ing the open arms of  the elevated plus-
maze (F(1,44) = 6.10, p < 0.05, Figure 1). 
Figure 1.  Effects of  U-50,488 and nor-BNI on percent of  time spent on the open arms of  the 
elevated plus-maze.  Rats were pretreated with nor-BNI or vehicle at least 24 hours prior to injec-
tion of  U-50,488 (0 or 10 mg/kg).  Injections of  U-50,488 occurred 10 minutes before testing in 
the elevated plus-maze.  Percent open arm time was calculated as the percent of  open arm time / 
(open + closed) arm time.  * p < 0.05 compared to vehicle, 0 mg/kg U-50,488 group, Tukey’s test.
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Injections of  10 mg/kg U-50,488 signifi-
cantly decreased percent open arm time 
compared to controls, an effect reversed 
by pretreatment with 20 mg/kg nor-BNI. 
No significant effects of  U-50,488 or nor-
BNI on the percentage of  open arm en-
tries were found (Figure 2).
A main effect of  nor-BNI was found on 
the total number of  arm entries (F(1,44) = 
11.73, p < 0.05, Figure 3).  Further analy-
sis revealed that pretreatment with nor-
BNI led to an increased number of  arm 
entries in rats injected with U-50,488.
Discussion 
 The principle finding of  this study is 
that the kappa opioid agonist U-50,488 
decreased open arm exploration in the 
elevated plus-maze, and this effect was 
attenuated by the kappa opioid antago-
nist nor-BNI.  These results suggest that 
stress-related behaviors are at least in part 
mediated by the activity of  the endoge-
nous kappa opioid system. 
 The time spent exploring the open 
arms of  the elevated plus-maze can be 
considered a measure of  emotionality. 
Rats naturally prefer the enclosed arms of  
the maze and spend more time in closed 
arms than in the open arms (Pellow, et al., 
1985).  Figure 1 illustrates a significant 
decrease in the amount of  time spent on 
the open arms by rats treated with 10 m/
kg of  U-50,488 compared to those that 
received no treatment.  This decrease in 
activity caused by U-50,488 indicates an 
increase in an anxiety-like state in the rat. 
We can conclude that the reversal of  the 
effects by the kappa opioid antagonist 
nor-BNI is not due to a different opi-
oid system, given that nor-BNI has been 
shown to exhibit maximum selectivity of  
kappa opioid receptors 24 hours after in-
jection (Endoh, et al., 1992).  This find-
ing is consistent with previous studies that 
have found nor-BNI to reverse the effects 
of  U-50,488 on the reinforcing efficacy of  
cocaine (Mclaughlin, et al., 2003, 2006a, 
2006b; Negus, 2004).
 The results failed to indicate a signifi-
cant effect of  U-50,488 or nor-BNI on 
percent of  open arm entries.  The per-
cent of  open arm entries is thought to be 
a measure of  anxiety, given that anxiolytic 
compounds would be expected to increase 
the number of  open arm entries without 
increasing the exploration of  the enclosed 
arms (Pellow, et al., 1985).  Although we 
did not achieve significant results in the 
percent of  open arm entries, this mea-
surement was not validated to correlate 
with other measurements of  anxiety, like 
the number of  arm entries or time spent 
on the open arms (Pellow, et al., 1985). 
 The total number of  arm entries on 
the elevated plus-maze is a measurement 
of  general locomotor activity of  the rat 
(Pellow, et al., 1985).  Previous research 
has suggested that altering kappa opioid 
activity can lead to general untoward mo-
tor effects (Negus, 2004).  Exposure to a 
novel environment such as the elevated 
plus-maze is in itself  anxiogenic and can 
result in an increase in time spent immo-
bile (Lister, 1987).  Typically, rats exposed 
to stress in a novel environment exhibit a 
decrease in motor activity and an increase 
in anxiety-related behavior, such as freez-
ing or immobility (Pellow, et al., 1985). 
However, nor-BNI led to increased loco-
motion in rats injected with U-50,488, 
suggesting that this overall increase in 
activity may be a further indication of  
Figure 2.  Effects of  U-50,488 and nor-BNI on the percent of  open arm entries in the elevated plus-
maze.  Rats were pretreated with nor-BNI or vehicle at least 24 hours prior to injection of  U-50,488 
(0 or 10 mg/kg).  Injections of  U-50,488 occurred 10 minutes before testing in the elevated plus-
maze.  Percent open arm entries was calculated as the number of  open arm entries / (open + closed) 
arm entries.  Neither U-50,488 or nor-BNI significantly altered the percentage of  open arm entries.
the elevated plus-maze.  Percent open arm time was calculated as the percent of  open arm time / 
(open + closed) arm time.  * p < 0.05 compared to vehicle, 0 mg/kg U-50,488 group, Tukey’s test.
Figure 3.  Effects of  U-50,488 and nor-BNI on total number of  arm entries.  Rats were pretreated 
with nor-BNI or vehicle at least 24 hours prior to injection of  U-50,488 (0 or 10 mg/kg).  Injections 
of  U-50,488 occurred 10 minutes before testing in the elevated plus-maze.  * p < 0.05 compared to 
vehicle, 10 mg/kg U-50,488 group, Tukey’s test.
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the anxiolytic effects of  nor-BNI.  The 
results revealed a main effect of  nor-BNI 
on the total number of  arm entries in the 
elevated plus-maze (Figure 3).  If  the to-
tal number of  arm entries is an indicator 
of  anxiety, then an increase in number of  
arm entries would suggest a decrease in 
an anxiety-like state in the rat. 
 In summary, U-50,488 produced 
anxiogenic-like properties in rats tested 
on the elevated plus-maze.  The effects 
of  U-50,488 were reversed by the kappa 
opioid agonist nor-BNI.  These results 
indicate that the kappa opioid system is 
involved in the regulation of  anxiety-like 
behavior in animals.  Understanding the 
role of  the kappa opioid system in the 
regulation of  behavioral stress responses 
may be crucial in understanding the 
mechanisms of  stress-related disorders 
and provide insight into the potential 
therapeutic value of  targeting the kappa 
opioid system for treatment of  anxiety 
and other stress-linked disorders.
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